--Must See--
Dr. Reddy’s Recalls 1000 Docetaxel Injection Vials from the US
A total of 1,051 vials of Docetaxel injection 20 mg/mL distributed in the United States, Myanmar and Uzbekistan by Pharma Major, Dr.Reddy’s has now been recalled.
The FDA stated that it is a class II recall. A class II recall is initiated when “use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where probability of serious adverse health consequences is remote.”
A drug used to treat cancer- the Docetaxel injection vials, were manufactured in the company’s Visakhapatnam facility.
